| |
|
|
| Name: |
Octagon Capital Advisors LP |
| City: |
NEW YORK |
| State: |
NY |
| Zip: |
10065 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
46 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
APLS |
Apellis Pharmaceuticals Inc |
1 |
- |
$49.86 |
$168,026,000 |
2,806,980 |
26.88% |
48,961,000 |
-323,020 |
2.452 |
N/A |
|
|
CBAY |
Cymabay Therapeutics, Inc. |
2 |
- |
$32.48 |
$63,154,000 |
2,673,750 |
10.1% |
17,324,000 |
-400,000 |
2.822 |
N/A |
|
|
VRNA |
Verona Pharma Plc |
3 |
- |
$0.00 |
$47,096,000 |
2,369,000 |
7.54% |
8,481,000 |
0 |
3.23 |
N/A |
|
|
INSM |
Insmed Inc |
4 |
- |
$24.80 |
$39,791,000 |
1,284,000 |
6.37% |
7,370,000 |
0 |
0.847 |
Biotechnology |
|
|
RCUS |
Arcus Biosciences Inc |
5 |
- |
$15.55 |
$35,679,000 |
1,868,000 |
5.71% |
353,000 |
-100,000 |
2.877 |
N/A |
|
|
BBIO |
Bridgebio Pharma, Inc. |
6 |
- |
$24.88 |
$28,534,000 |
706,800 |
4.57% |
2,912,000 |
-264,839 |
0.444 |
N/A |
|
|
CLDX |
Celldex Therapeutics Inc |
7 |
- |
$36.30 |
$28,060,000 |
707,526 |
4.49% |
7,148,000 |
-52,372 |
1.351 |
Diagnostic Substances |
|
|
ROIV |
Roivant Sciences Ltd. |
8 |
- |
$11.03 |
$28,008,000 |
2,494,000 |
4.48% |
-22,999,000 |
-1,873,000 |
0.36 |
N/A |
|
|
ALPN |
Alpine Immune Sciences Inc |
9 |
- |
$64.56 |
$23,659,000 |
1,241,300 |
3.79% |
15,071,000 |
491,300 |
2.704 |
N/A |
|
|
GPCR |
Structure Therapeutics Inc. |
10 |
- |
$38.94 |
$16,875,000 |
414,000 |
2.7% |
16,875,000 |
414,000 |
1.082 |
N/A |
|
|
CNTA |
Centessa Pharmaceuticals Plc |
11 |
- |
$0.00 |
$16,398,000 |
2,060,100 |
2.62% |
13,321,000 |
1,584,500 |
2.357 |
N/A |
|
|
ANTX |
An2 Therapeutics Ord Shs |
12 |
- |
$2.32 |
$13,617,000 |
664,575 |
2.18% |
-334,000 |
-203,000 |
3.424 |
N/A |
|
|
VRDN |
Viridian Therapeutics Ors Shs |
13 |
- |
$12.88 |
$13,504,000 |
620,000 |
2.16% |
-2,866,000 |
-447,143 |
1.368 |
N/A |
|
|
IMVT |
Immunovant Inc |
14 |
New |
$0.00 |
$11,514,000 |
273,289 |
1.84% |
11,514,000 |
273,289 |
0.314 |
N/A |
|
|
DYN |
Dyne Therapeutics, Inc. |
15 |
- |
$24.73 |
$10,546,000 |
792,945 |
1.69% |
4,337,000 |
100,000 |
1.391 |
N/A |
|
|
CYTK |
Cytokinetics Inc |
16 |
New |
$65.34 |
$9,685,000 |
116,000 |
1.55% |
9,685,000 |
116,000 |
0.103 |
Biotechnology |
|
|
ANNX |
Annexon, Inc. |
17 |
- |
$0.00 |
$9,307,000 |
2,050,000 |
1.49% |
4,469,000 |
0 |
2.381 |
N/A |
|
|
AVTE |
Aerovate Therapeutics, Inc. |
18 |
- |
$0.00 |
$9,135,000 |
403,685 |
1.46% |
2,386,000 |
-93,685 |
1.523 |
N/A |
|
|
GOSS |
Gossamer Bio Inc |
19 |
- |
$0.67 |
$8,384,000 |
9,187,883 |
1.34% |
1,565,000 |
1,000,000 |
9.725 |
N/A |
|
|
RAPT |
Rapt Therapeutics, Inc. |
20 |
New |
$8.10 |
$7,256,000 |
292,000 |
1.16% |
7,256,000 |
292,000 |
0.809 |
N/A |
|
|
GLYC |
Glycomimetics Inc |
21 |
- |
$1.64 |
$7,080,000 |
3,000,000 |
1.13% |
2,580,000 |
0 |
6.272 |
N/A |
|
|
GRCL |
Gracell Biotechnologies Adr... |
22 |
New |
$0.00 |
$5,990,000 |
596,611 |
0.96% |
5,990,000 |
596,611 |
0.888 |
N/A |
|
|
DNTH |
Dianthus Therapeutics Ord Shs |
23 |
- |
$0.70 |
$5,762,000 |
554,000 |
0.92% |
-800,000 |
74,000 |
3.738 |
N/A |
|
|
RPHM |
Reneo Pharmaceuticals, Inc. |
24 |
- |
$1.67 |
$3,600,000 |
2,250,000 |
0.58% |
-13,761,000 |
-29,870 |
9.263 |
N/A |
|
|
JSPR |
Jasper Therapeutics Ord Shs |
25 |
- |
$15.12 |
$3,525,000 |
4,468,114 |
0.56% |
397,000 |
0 |
4.399 |
N/A |
|
|
VERU |
Veru Inc |
26 |
New |
$1.27 |
$2,736,000 |
3,800,000 |
0.44% |
2,736,000 |
3,800,000 |
5.439 |
Personal Products |
|
|
ANAB |
Anaptysbio Inc |
27 |
New |
$21.00 |
$2,570,000 |
120,000 |
0.41% |
2,570,000 |
120,000 |
0.377 |
N/A |
|
|
INZY |
Inozyme Pharma, Inc. |
28 |
- |
$0.00 |
$1,704,000 |
400,000 |
0.27% |
-3,756,000 |
-900,000 |
0.648 |
N/A |
|
|
NUVB |
Nuvation Bio Ord Shs Class A |
29 |
New |
$10.42 |
$1,510,000 |
1,000,000 |
0.24% |
1,510,000 |
1,000,000 |
0.462 |
N/A |
|
|
XLO |
Xilio Therapeutics, Inc. |
30 |
- |
$0.00 |
$982,000 |
1,785,000 |
0.16% |
-3,910,000 |
-533,500 |
6.693 |
N/A |
|
|
MIRM |
Mirum Pharmaceuticals, Inc. |
31 |
New |
$0.00 |
$738,000 |
25,000 |
0.12% |
738,000 |
25,000 |
0.068 |
N/A |
|
|
PHAT |
Phathom Pharmaceuticals, Inc. |
32 |
New |
$0.00 |
$457,000 |
50,000 |
0.07% |
457,000 |
50,000 |
0.147 |
N/A |
|
|
ACRS |
Aclaris Therapeutics, Inc. |
33 |
New |
$1.20 |
$105,000 |
100,000 |
0.02% |
105,000 |
100,000 |
0.135 |
N/A |
|
|
VKTX |
Viking Therapeutics, Inc. |
41 |
Closed |
$74.31 |
$0 |
0 |
0% |
-4,151,000 |
-375,000 |
0 |
N/A |
|
|
BNOX |
Bionomics Ads |
36 |
Closed |
$0.00 |
$0 |
0 |
0% |
-454,000 |
-168,000 |
0 |
N/A |
|
|
TSHA |
Taysha Gene Therapies, Inc. |
43 |
Closed |
$0.00 |
$0 |
0 |
0% |
-8,778,000 |
-2,777,778 |
0 |
N/A |
|
|
AMLX |
Amylyx Pharmaceuticals, Inc. |
40 |
Closed |
$0.00 |
$0 |
0 |
0% |
-12,725,000 |
-695,000 |
0 |
N/A |
|
|
GLUE |
Monte Rosa Therapeutics, Inc. |
35 |
Closed |
$0.00 |
$0 |
0 |
0% |
-3,894,000 |
-812,895 |
0 |
N/A |
|
|
ORIC |
Oric Pharmaceuticals, Inc. |
39 |
Closed |
$0.00 |
$0 |
0 |
0% |
-1,237,000 |
-204,500 |
0 |
N/A |
|
|
LXRX |
Lexicon Pharmaceuticals Inc |
42 |
Closed |
$1.58 |
$0 |
0 |
0% |
-2,096,000 |
-1,923,076 |
0 |
Diagnostic Substances |
|
|
PMVP |
Pmv Pharmaceuticals, Inc. |
46 |
Closed |
$0.00 |
$0 |
0 |
0% |
-5,551,000 |
-904,000 |
0 |
N/A |
|
|
HEPA |
Hepion Pharmaceuticals, Inc |
34 |
Closed |
$1.37 |
$0 |
0 |
0% |
-337,000 |
-67,500 |
0 |
N/A |
|
|
ITOS |
Iteos Therapeutics, Inc. |
38 |
Closed |
$0.00 |
$0 |
0 |
0% |
-1,117,000 |
-102,000 |
0 |
N/A |
|
|
VIR |
Vir Biotechnology, Inc. |
45 |
Closed |
$0.00 |
$0 |
0 |
0% |
-3,046,000 |
-325,050 |
0 |
N/A |
|
|
MRTX |
Mirati Therapeutics, Inc. |
44 |
Closed |
$58.70 |
$0 |
0 |
0% |
-28,534,000 |
-655,051 |
0 |
Biotechnology |
|
|
ETNB |
89bio, Inc. |
37 |
Closed |
$8.26 |
$0 |
0 |
0% |
-18,824,000 |
-1,219,157 |
0 |
N/A |
|
